These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
406 related items for PubMed ID: 1310554
21. Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat. Hsu CL, Fabritius C, Dudley J. J Virol; 1988 Dec; 62(12):4644-52. PubMed ID: 2846876 [Abstract] [Full Text] [Related]
22. Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses. Bigornia L, Lockridge KM, Sparger EE. J Virol; 2001 Jan; 75(2):1054-60. PubMed ID: 11134320 [Abstract] [Full Text] [Related]
23. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA. Lockridge KM, Chien M, Dean GA, Stefano Cole K, Montelaro RC, Luciw PA, Sparger EE. Virology; 2000 Jul 20; 273(1):67-79. PubMed ID: 10891409 [Abstract] [Full Text] [Related]
24. Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR. Seeler JS, Muchardt C, Podar M, Gaynor RB. Virology; 1993 Oct 20; 196(2):442-50. PubMed ID: 8372429 [Abstract] [Full Text] [Related]
25. A CRE/ATF-like site in the upstream regulatory sequence of the human interleukin 1 beta gene is necessary for induction in U937 and THP-1 monocytic cell lines. Gray JG, Chandra G, Clay WC, Stinnett SW, Haneline SA, Lorenz JJ, Patel IR, Wisely GB, Furdon PJ, Taylor JD. Mol Cell Biol; 1993 Nov 20; 13(11):6678-89. PubMed ID: 8413264 [Abstract] [Full Text] [Related]
27. Extra mouse mammary tumor proviruses in DBA/2 mouse lymphomas acquire a selective advantage in lymphocytes by alteration in the U3 region of the long terminal repeat. Yanagawa S, Murakami A, Tanaka H. J Virol; 1990 Jun 20; 64(6):2474-83. PubMed ID: 2159524 [Abstract] [Full Text] [Related]
28. Molecular characterization and heterogeneity of feline immunodeficiency virus isolates. Maki N, Miyazawa T, Fukasawa M, Hasegawa A, Hayami M, Miki K, Mikami T. Arch Virol; 1992 Jun 20; 123(1-2):29-45. PubMed ID: 1312825 [Abstract] [Full Text] [Related]
29. Comparison of the transcriptional activity of the long terminal repeats of simian immunodeficiency viruses SIVmac251 and SIVmac239 in T-cell lines and macrophage cell lines. Anderson MG, Clements JE. J Virol; 1991 Jan 20; 65(1):51-60. PubMed ID: 1985214 [Abstract] [Full Text] [Related]
30. Comparative functional analysis of the various lentivirus long terminal repeats in human colon carcinoma cell line (SW480 cells) and feline renal cell line (CRFK cells). Miyazawa T, Kawaguchi Y, Kohmoto M, Tomonaga K, Mikami T. J Vet Med Sci; 1994 Oct 20; 56(5):895-9. PubMed ID: 7865591 [Abstract] [Full Text] [Related]
31. The genome of feline immunodeficiency virus. Miyazawa T, Tomonaga K, Kawaguchi Y, Mikami T. Arch Virol; 1994 Oct 20; 134(3-4):221-34. PubMed ID: 8129613 [Abstract] [Full Text] [Related]
32. A variant binding sequence for transcription factor EBP-80 confers increased promoter activity on a retroviral long terminal repeat. Falzon M, Kuff EL. J Biol Chem; 1990 Aug 05; 265(22):13084-90. PubMed ID: 2165492 [Abstract] [Full Text] [Related]
33. Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity. Gemeniano MC, Sawai ET, Leutenegger CM, Sparger EE. J Virol; 2003 Aug 05; 77(16):8819-30. PubMed ID: 12885901 [Abstract] [Full Text] [Related]
34. Proviral organization and sequence analysis of feline immunodeficiency virus isolated from a Pallas' cat. Barr MC, Zou L, Long F, Hoose WA, Avery RJ. Virology; 1997 Feb 03; 228(1):84-91. PubMed ID: 9024812 [Abstract] [Full Text] [Related]
35. Transcriptional interaction between retroviral long terminal repeats (LTRs): mechanism of 5' LTR suppression and 3' LTR promoter activation of c-myc in avian B-cell lymphomas. Boerkoel CF, Kung HJ. J Virol; 1992 Aug 03; 66(8):4814-23. PubMed ID: 1321271 [Abstract] [Full Text] [Related]
36. Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. Phillips TR, Lamont C, Konings DA, Shacklett BL, Hamson CA, Luciw PA, Elder JH. J Virol; 1992 Sep 03; 66(9):5464-71. PubMed ID: 1323707 [Abstract] [Full Text] [Related]
37. Multiple, Independent T Cell Lymphomas Arising in an Experimentally FIV-Infected Cat during the Terminal Stage of Infection. Murphy BG, Eckstrand C, Castillo D, Poon A, Liepnieks M, Harmon K, Moore P. Viruses; 2018 May 24; 10(6):. PubMed ID: 29794987 [Abstract] [Full Text] [Related]
38. Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity. de Parseval A, Elder JH. J Virol; 1999 Jan 24; 73(1):608-17. PubMed ID: 9847366 [Abstract] [Full Text] [Related]
39. Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity. Kliewer S, Garcia J, Pearson L, Soultanakis E, Dasgupta A, Gaynor R. J Virol; 1989 Nov 24; 63(11):4616-25. PubMed ID: 2529378 [Abstract] [Full Text] [Related]
40. In vitro characterization of FIV-pPPR, a pathogenic molecular clone of feline immunodeficiency virus, and two drug-resistant pol gene mutants. McCrackin Stevenson MA, McBroom DG. Am J Vet Res; 2001 Apr 24; 62(4):588-94. PubMed ID: 11327469 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]